Lipid-Drug Conjugates: Innovation and Applications highlights the most recent advances and clinical applications of nano lipid-drug conjugates for enhanced drug delivery and targeting in the treatment of cancer, glioblastoma, Alzheimer’s, AIDS, and bacterial diseases. In addition, various conjugation methods to prepare lipid-drug conjugates and their pharmacokinetics in vivo are explored, together with the production and characterization of various delivery carriers for lipid-drug conjugates. The contents of this book provide pharmaceutical science researchers with the tools to explore targeted drug delivery leveraging the unique characteristics of lipid conjugates. Scientists in the corporate setting can benefit of the cases and techniques presented in developing new formulations and products.
1. 10.1 Introduction - p. 237 2. 10.2 Nanotechnology in the treatment of Alzheimer’s disease - p. 239 3. 10.3 Nano lipid-drug conjugates - p. 263 4. 10.4 Applications of nano lipid-drug conjugates in Alzheimer’s disease - p. 268 5. 10.5 Preclinical and clinical evidences of nano lipid-drug conjugates in the treatment of Alzheimer’s disease - p. 271 6. 10.6 Safety and toxicity considerations - p. 271 7. 10.7 Conclusion and future perspectives - p. 274 8. References - p. 274 9. Chapter 11. Lipid-drug conjugates for the treatment of glioblastomas - p. 293 10. Chapter 12. Antibody drug conjugates integrated with lipid nanocarrier for cancer theranostics - p. 333 11. Chapter 13. Antibacterial drug conjugates for bacterial diseases - p. 365 12. Chapter 14. Lipid-drug conjugates: future perspectives, industry trends and global forecast - p. 383 13. Index - p. 399
Lipid-Drug Conjugates: Innovation and Applications highlights the most recent advances and clinical applications of nano lipid-drug conjugates for enhanced drug delivery and targeting in the treatment of cancer, glioblastoma, Alzheimer’s, AIDS, and bacterial diseases. In addition, various conjugation methods to prepare lipid-drug conjugates and their pharmacokinetics in vivo are explored, together with the production and characterization of various delivery carriers for lipid-drug conjugates. The contents of this book provide pharmaceutical science researchers with the tools to explore targeted drug delivery leveraging the unique characteristics of lipid conjugates. Scientists in the corporate setting can benefit of the cases and techniques presented in developing new formulations and products.
1. 10.1 Introduction - p. 237 2. 10.2 Nanotechnology in the treatment of Alzheimer’s disease - p. 239 3. 10.3 Nano lipid-drug conjugates - p. 263 4. 10.4 Applications of nano lipid-drug conjugates in Alzheimer’s disease - p. 268 5. 10.5 Preclinical and clinical evidences of nano lipid-drug conjugates in the treatment of Alzheimer’s disease - p. 271 6. 10.6 Safety and toxicity considerations - p. 271 7. 10.7 Conclusion and future perspectives - p. 274 8. References - p. 274 9. Chapter 11. Lipid-drug conjugates for the treatment of glioblastomas - p. 293 10. Chapter 12. Antibody drug conjugates integrated with lipid nanocarrier for cancer theranostics - p. 333 11. Chapter 13. Antibacterial drug conjugates for bacterial diseases - p. 365 12. Chapter 14. Lipid-drug conjugates: future perspectives, industry trends and global forecast - p. 383 13. Index - p. 399
